Two Seas Capital LP Invests $103.59 Million in Sotera Health Company $SHC

Two Seas Capital LP bought a new position in Sotera Health Company (NASDAQ:SHC) during the second quarter, Holdings Channel reports. The firm bought 5,836,053 shares of the company’s stock, valued at approximately $103,590,000. Sotera Health makes up about 2.1% of Two Seas Capital LP’s portfolio, making the stock its 11th biggest holding.

Several other hedge funds and other institutional investors have also recently bought and sold shares of SHC. Evolve Private Wealth LLC purchased a new position in Sotera Health during the second quarter valued at approximately $207,000. Ieq Capital LLC purchased a new stake in Sotera Health in the 2nd quarter worth approximately $1,747,000. Allworth Financial LP purchased a new stake in Sotera Health in the 2nd quarter worth approximately $262,000. West Family Investments Inc. purchased a new stake in Sotera Health in the 2nd quarter worth approximately $225,000. Finally, Meeder Asset Management Inc. acquired a new stake in shares of Sotera Health during the 2nd quarter worth approximately $37,000. 91.03% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on SHC. Citigroup lifted their target price on shares of Sotera Health from $23.00 to $25.00 and gave the company a “buy” rating in a report on Friday, August 7th. The Goldman Sachs Group started coverage on shares of Sotera Health in a report on Friday, June 5th. They set a “buy” rating and a $20.00 price target on the stock. Barclays raised their price target on shares of Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. JPMorgan Chase & Co. lifted their price objective on shares of Sotera Health from $16.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, August 7th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $25.00 price objective (up from $22.00) on shares of Sotera Health in a research report on Friday, August 7th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $21.50.

Sotera Health Stock Up 1.8%

Shares of SHC opened at $19.57 on Friday. The company has a current ratio of 2.80, a quick ratio of 2.55 and a debt-to-equity ratio of 3.33. Sotera Health Company has a 12 month low of $13.09 and a 12 month high of $19.85. The stock’s 50 day moving average is $17.77 and its two-hundred day moving average is $16.36. The firm has a market cap of $5.58 billion, a P/E ratio of 34.33 and a beta of 1.77.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. The business had revenue of $321.38 million during the quarter, compared to analysts’ expectations of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The business’s revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.20 earnings per share. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Analysts predict that Sotera Health Company will post 0.86 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Sotera Health news, insider Michael P. Rutz sold 150,000 shares of the company’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the transaction, the insider directly owned 334,279 shares in the company, valued at approximately $6,297,816.36. This represents a 30.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the company’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the transaction, the chairman owned 3,969,393 shares of the company’s stock, valued at $73,433,770.50. This represents a 17.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 1,294,515 shares of company stock worth $23,999,528 in the last three months. 15.36% of the stock is owned by corporate insiders.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.